Benzydamine for oromucosal use is indicated in the relief of pain and irritation of the mouth and throat. It is an indazole derivative, non-steroidal anti-inflammatory drug, with combined local anesthetic and analgesic properties, and antiseptic activity, marketed under the brand name “Tantum Verde”. The aim of this study was to explore knowledge and prescriptive/advising attitudes among general practitioners (GPs) and pharmacists (PHs) with regard to the topical treatment of sore throat and other irritative/inflammatory conditions of the oropharynx, with a focus on benzydamine. These findings could be important to increase awareness on benzydamine efficacy in sore throat and stomatological conditions, and to reinforce knowledge on the characteristics of benzydamine and its mechanisms of action among healthcare professionals (pediatricians, otolaryngologists, oncologists, etc.).

Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners / Passali, Desiderio; Arezzo, Maria Felice; DE ROSE, Alessandra; De Simone, Gianmarco; Forte, Gianluigi; Jablko‑musial, Michalina; Mösges, Ralph. - In: BMC PRIMARY CARE. - ISSN 2731-4553. - 154:23(2022).

Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners

Desiderio Passali
;
Maria felice Arezzo;Alessandra De Rose;
2022

Abstract

Benzydamine for oromucosal use is indicated in the relief of pain and irritation of the mouth and throat. It is an indazole derivative, non-steroidal anti-inflammatory drug, with combined local anesthetic and analgesic properties, and antiseptic activity, marketed under the brand name “Tantum Verde”. The aim of this study was to explore knowledge and prescriptive/advising attitudes among general practitioners (GPs) and pharmacists (PHs) with regard to the topical treatment of sore throat and other irritative/inflammatory conditions of the oropharynx, with a focus on benzydamine. These findings could be important to increase awareness on benzydamine efficacy in sore throat and stomatological conditions, and to reinforce knowledge on the characteristics of benzydamine and its mechanisms of action among healthcare professionals (pediatricians, otolaryngologists, oncologists, etc.).
2022
Sore throat; Benzydamine; Oropharynx; General practitioner
01 Pubblicazione su rivista::01a Articolo in rivista
Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners / Passali, Desiderio; Arezzo, Maria Felice; DE ROSE, Alessandra; De Simone, Gianmarco; Forte, Gianluigi; Jablko‑musial, Michalina; Mösges, Ralph. - In: BMC PRIMARY CARE. - ISSN 2731-4553. - 154:23(2022).
File allegati a questo prodotto
File Dimensione Formato  
Arezzo_Benzydamine-hydrochloride_2022.pdf.pdf

accesso aperto

Note: Arezzo_Benzydamine-hydrochloride_2022.pdf
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 736.71 kB
Formato Adobe PDF
736.71 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1651475
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact